1/67
Lecture 10
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
outer part
cortical (compact) bone
80% of skeletal mass
gives bone much of its strength
inner compartment
trabecular (cancellous) bone
20% of mass
made up of interconnected plates called trabeculae
trabeculae
sites of active remodeling
osteoid
bone is living tissue composed of organic extracellular matrix
bone
is impregnated with hydroxyapatite crystals are largely Ca3(PO4)2 salts
these stores may be mobilized
when plasma Ca falls
so bone remodeling is involved in Ca homeostasis
remodeling via
bone deposition/resorption
maintains skeletal strength and health
human skeleton
turns over every 10 years
osteoclasts
responsible for bone resorption (breakdown)
osteoblasts
responsible for laying down new bone
bone remodeling steps
osteoclast recruitment and activation
resorption and osteoblast recruitment
osteoblastic bone formation
completed remodeling cycle
RANK-L
made by osteoblast and bone marrow stromal cells
osteoclast precursor
cell death
dec bone mass
osteoclast
OPG osteoprotegerin
produces by marrow cells
inc bone mass
osteoblast
osteoblasts make
RANK-L and OPG
balance determines the outcome on bone mass
OPG low and RANK-L high
osteoclast favored
dec bone mass
OPG high and RANK-L low
osteoblast favored
inc bone mass
calcium be liberated
osteoclast and dec bone mass
hypocalcemia
dec Ca
inc Na influx
resting potential closer to threshold
inc neuromuscular excitability
spasm
hypercalcemia
inc Ca
dec neuromuscular excitability and car
excitation-contraction coupling
in cardiac and smooth muscle
stimulus-secretion coupling
Ca triggers exocytosis of NT and peptides
excitation-secretion coupling
pancreatic B-cells
membrane depolarization causes inc Ca entry and insulin secretion
maintenance of
tight junctions between cells
clotting of blood
Ca is a cofactor in clot formation
calcium homeostasis
controlled by hormones acting on bone
endocrine system regulates
plasma concentrations of inorganic electrolytes
Na, K, Ca, PO43-
main regulators
parathyroid hormone (PTH)
calcitonin
vitamin D
99% of calcium is
crystalline form in skeleton and teeth
bone is a reservoir of calcium
remaining 1%
is in extracellular fluid
plasma protein bound
ionized
complexed to organic ions
parathyroid hormone
stimulus: low serum Ca
origin: PTH gland
inc Ca
dec phosphate
vitamin D
stimulus: low serum Ca, low phosphate, PTH
origin: skin then metabolized in liver and kidney
inc Ca
inc phosphate
fibroblast growth factor 23
stimulus: high serum phosphate
origin: osteocytes in bone matrix
dec phosphate
calcitonin
stimulus: high Ca
origin: parafollicular C cells of thyroid gland
dec Ca
calcium
exchanges across osteocytic-osteoblastic bone membrane
parathyroid hormone (PTH)
released when serum Ca decrease
PTH
secreted by parathyroid glands
peptide hormone
metabolized by liver
metabolites cleared by kidney
responsive to
alteraction in Ca concentrations
low Ca
stimulate PTH secretion
high Ca
suppresses PTH synthesis and secretion
PTH producing cells
express an extracellular calcium-sensing receptor
Ca high
CaSR is activated
inhibiting the release of PTH
Ca low
CaSR is inactive
PTH is released
chronic hypocalcemia
stimulates proliferation of the PTH gland
leads to hyperplasia
type 1 PTH receptor
mediates PTH effects on Ca
GPCR
expressed on osteoclasts and osteoblasts
recognizes PTH and PTH-related peptide
type 2 PTH receptor
expressed on other tissues
specific to PTH
PTH
stimulates Ca release from bone
enhances osteoclast by stimulating RANK-L
stimulates reabsorption
of Ca in the kidney
inhibits
phosphate reabsorption
promotes phosphate excretion
stimulates
production of vitamin D
increases intestinal Ca reabsorption
inc Ca
negative feedback is exerted on PTH gland
vitamin d
pro hormone produced in the dermis in response to UV-B exposure
metabolized to active forms in liver then kidney
active hormone
1,25-(OH)2-D3
PTH stimulates
the synthesis of vitamin d
integrates stimulation of Ca homeostasis
vitamin d
enhances intestinal reabsorption of Ca
vitamin d stimulated
by hypocalcemia and hypophosphatemia, FGF-23 and low PTH
vitamin d inhibited
by hypercalcemia and hyperphosphatemia
vitamin d supplements
contain pro hormone
vitamin d receptor
member of steroid hormone receptor family
derives from cholesterol
in the intestine
it stimulates active intestinal transport of Ca in the duodenum
enabling Ca absorption
in bone
regulates osteoblasts/osteoclast function to favor the osteoclast path
through RANK
helps to increase plasma Ca
vitamin d promotes
intestinal absorption of phosphorus
fibroblast growth factor-23
regulates phosphate homeostasis
stimulated when phosphate is high
restores serum phosphate to physiological levels
phys of FGF-23
produced by osteocytes in bone matrix
effects are mediated by FGF receptors and co-receptor transmembrane protein, klotho
calcitonin
peptide hormone
produced by parafollicular C cells of thyroid gland
C cells
<0.1% of thyroid mass
distributed through the gland
hypercalcemia
stimulates the release of calcitonin
via CaSRs in C cells
calcitonin actions
lower serum Ca
rapidly released upon hypercalcemia
targets are bone and kidney
acts directly on osteoclasts (inhibitory) to block bone resorption
counterregulatory to PTH, vitamin D
pathophy calcitonin
medullary carcinoma of the thyroid- a C-cell neoplasm, accounting for 5-10% of thyroid malignancies